Profusa (PFSA) Other Non Operating Income (2024 - 2026)

Profusa posted quarterly Other Non Operating Income of $71000.0 for Q1 2026, up 145.51% year-on-year from $28919.1 in Q1 2025, and down 99.01% on a QoQ basis from $7.2 million in Q4 2025.

Profusa (PFSA) has 3 years of Other Non Operating Income data on file, last reported at $71000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Non Operating Income rose 145.51% year-over-year to $71000.0; the trailing twelve-month figure through Mar 2026 stood at $7.4 million (changed N/A YoY), and the FY2025 full-year result was $3.3 million, up 65780.0% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at $71000.0, down from $7.2 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $7.2 million in Q4 2025 and bottomed at -$156000.0 in Q1 2025.
  • The 3-year median for Other Non Operating Income is $71000.0 (2026), against an average of $1.5 million.
  • The widest annual swing landed in 2025, when Other Non Operating Income surged 25900.0%; it then jumped 145.51% in 2026.
  • A 3-year view of Other Non Operating Income shows it stood at -$1000.0 in 2024, then surged by 719300.0% to $7.2 million in 2025, then tumbled by 99.01% to $71000.0 in 2026.
  • The last three Other Non Operating Income figures came in at $71000.0 (Q1 2026), $7.2 million (Q4 2025), and $258000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Profusa 574,294.01 574,294.01 -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 71,000.00
Dec 31, 2025 68,000.00
Sep 30, 2025 258,000.00
Dec 31, 2024 -316,000.00
Sep 30, 2024 -1,000.00